Ocular Therapeutix IPO Research Information

Ocular Therapeutix IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Ocular Therapeutix, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Ocular Therapeutix	OCUL - NASDAQ	$14.00-$16.00	$13.00	$13.00	5 million	7/25/2014
Underwriter(s): Morgan Stanley, Cowen & Co., RBC Capital Markets
Co-Manager(s): Oppenheimer & Co.,
Industry: Health Care
Filing(s): Filed 2014-06-23 Terms Added 2014-07-11

Ocular Therapeutix Quote & Chart - Click for current quote - OCUL

About Ocular Therapeutix (adapted from Ocular Therapeutix prospectus):
They are a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using our proprietary hydrogel platform technology.

This description is adapted from Ocular Therapeutix prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Ocular Therapeutix "OCUL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.